Valued at USD 1.41 billion in 2021, the carrier screening market is projected to reach USD 3.64 billion by 2030, growing at a CAGR of 11.7% during the forecast period of 2022–2030. Key players include MedGenome, Myriad Genetics, Natera Inc., Opko Health, Quest Diagnostics Incorporated, Roche AG, Sequenom Inc., Thermo Fisher Scientific Inc., and True Health. This article reviews technology...